Development of Fluorescent Lectin Tracers With Dedicated Technology for in Vivo Detection of Esophageal Dysplasia in Barrett Patients

NCT07643727 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Barrett's Esophagus With or Without Dysplasia
Barrett Esophagus Adenocarcinoma

Interventions

DRUG: WGA-800CW

Sponsor

University Medical Center Groningen